Similarly, multiple doses of CD34+ hematopoietic progenitor cell (HPC)-derived NK cells and IL-15 were given to animals bearing OvCa tumors treated with gemcitabine to improve tumor response [11]. The gene discussed is IL15; the disease is neoplasm.